PUBLISHER: Acute Market Reports | PRODUCT CODE: 1170487
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1170487
The global equine healthcare market held US$ 626.2 Mn in 2021 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2022 to 2030. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market. Horse racing for gambling and leisure purpose is highly active in region such as North America, Europe and Asia Pacific which stimulates the demand for equine healthcare products in the region. The companies operating in the market are engaging in research and development of novel products to gain competitive edge in the market.
In 2021, drugs segment held the largest share in the global equine healthcare market owing to growing demand for therapeutic drugs for the treatment of various diseases. Horses are highly prone to diseases such as tetanus, equine encephalomyelitis, rabies, equine influenza, West Nile virus among others which needs to be taken care of. The drugs segment is further segmented in to anti-infective, anti-inflammatory and anti-parasitic drugs. Vaccines held the second largest market is projected to grow at a steady rate during the forecast period. Supplements and additives are expected to exhibit fastest growth rate due to high product launch and growing awareness regarding the benefits of supplements among the equine care takers.
Market is studied in order to understand the current dynamics and future trends in the global equine healthcare market. The study includes market size and forecast for all considered segments presented in the report for the period from 2020 to 2030, along with respective compound annual growth rate (CAGRs) for the forecast period from 2022 to 2030, considering 2021 as the base year. The key players currently engaged in equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, Merck & Co. (Merck Animal Health) among others.
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Equine Healthcare market are as follows:
Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.